Jenburkt Pharmaceuticals Ltd

NSE: BSE: 524731

₹1003.90

(2.23%)

Sat, 12 Sept 2026, 08:01 am

MTF 5xInvest in Jenburkt Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)458.28

PE Ratio13.50

Dividend1.99

Health Technology

Pharmaceuticals: Major

24.5K

Jenburkt Pharmaceuticals News

Jenburkt Pharmaceuticals closes trading window

Jenburkt Pharmaceuticals Ltd closed its trading window from July 1, 2026, until 48 hours after Q1FY27 results are released.

18 Jun 2026

companies

Jenburkt Pharma Files FY26 Audited Results Under Reg 33

Jenburkt Pharmaceuticals published standalone audited financial results for Q4 and FY26 ended March 31, 2026, approved by the Board on May 5, 2026.

06 May 2026

companies

Jenburkt Pharmaceuticals confirms 'not a large corporate' status for FY26

Jenburkt Pharmaceuticals Limited disclosed to BSE that it maintains 'not a large corporate' status for financial year ended March 31, 2026, as per SEBI regulatory requirements.

14 Apr 2026

companies

Jenburkt Pharma Files Q4 FY26 Compliance Certificate

Jenburkt Pharmaceuticals submits mandatory quarterly certificate to BSE confirming compliance with SEBI dematerialization regulations for Q4 FY26 period ended March 31, 2026.

07 Apr 2026

companies

Jenburkt Pharmaceuticals Q3FY26 Results

Jenburkt Pharmaceuticals reported Q3FY26 revenue of Rs 4302.39 lacs and net profit of Rs 593.14 lacs. Nine-month revenue reached Rs 12410.83 lacs with profit of Rs 2388.66 lacs.

03 Feb 2026

co actions results

Showing 1–5 of 15

Rows per page:

Market Current News

Injecto Polymers IPO Day 1: Subscription at 0.06x

Injecto Polymers IPO sees modest demand on Day 1 with total subscription at 0.06x. Retail leads with 0.08x, while QIB remains flat. Issue closes on September 16.

11 Sept 2026

ipo

NSE IPO DRHP: ₹16,601 Cr Revenue, 99.79% Market Share

National Stock Exchange files DRHP for pure OFS of 12.64 crore shares. India's largest exchange reports FY26 revenue of ₹16,601 Cr and PAT of ₹10,302 Cr with dominant market share.

11 Sept 2026

ipo

Vinod Texworld IPO Day 3: Fully Subscribed

Vinod Texworld IPO crosses 1x mark on Day 3 with Retail driving demand. Total subscription stands at 1.16x as QIB remains flat. Check full subscription details.

11 Sept 2026

ipo

Asset Reconstruction Company IPO Day 3: QIB demand surges 588%

The Asset Reconstruction Company IPO is fully subscribed on Day 3 with a total subscription of 1.57x. QIB category saw a massive jump of 588% intraday, while NII (bHNI) leads at 2.88x.

11 Sept 2026

ipo

Century Business Media IPO Day 1: Weak Start

Century Business Media IPO opens on Day 1 with a subscription of just 0.08x. NII (bHNI) leads with 0.46x, while QIB and Retail show minimal interest. Check full details.

11 Sept 2026

ipo

Showing 1–5 of 94219

Rows per page: